Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19

Guardado en:

Detalles Bibliográficos
Autores principales:	Satvinder Singh Bakshi, Sumita Bakshi
Formato:	article
Lenguaje:	EN
Publicado:	SpringerOpen 2021
Materias:	Internal medicine RC31-1245
Acceso en línea:	https://doaj.org/article/58794a49ae3b433ab5feadeca7fc154b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:58794a49ae3b433ab5feadeca7fc154b
record_format	dspace
spelling	oai:doaj.org-article:58794a49ae3b433ab5feadeca7fc154b2021-11-14T12:05:45ZLetter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-1910.1186/s43162-021-00070-z1110-77822090-9098https://doaj.org/article/58794a49ae3b433ab5feadeca7fc154b2021-11-01T00:00:00Zhttps://doi.org/10.1186/s43162-021-00070-zhttps://doaj.org/toc/1110-7782https://doaj.org/toc/2090-9098Satvinder Singh BakshiSumita BakshiSpringerOpenarticleInternal medicineRC31-1245ENThe Egyptian Journal of Internal Medicine, Vol 33, Iss 1, Pp 1-2 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Internal medicine RC31-1245
spellingShingle	Internal medicine RC31-1245 Satvinder Singh Bakshi Sumita Bakshi Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
format	article
author	Satvinder Singh Bakshi Sumita Bakshi
author_facet	Satvinder Singh Bakshi Sumita Bakshi
author_sort	Satvinder Singh Bakshi
title	Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
title_short	Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
title_full	Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
title_fullStr	Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
title_full_unstemmed	Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
title_sort	letter to the editor—a need to strengthen the adverse drug reaction reporting during covid-19
publisher	SpringerOpen
publishDate	2021
url	https://doaj.org/article/58794a49ae3b433ab5feadeca7fc154b
work_keys_str_mv	AT satvindersinghbakshi lettertotheeditoraneedtostrengthentheadversedrugreactionreportingduringcovid19 AT sumitabakshi lettertotheeditoraneedtostrengthentheadversedrugreactionreportingduringcovid19
_version_	1718429465196888064

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19

Ejemplares similares